Cryo Cell grants director Mizrahi 5,300 stock options

The award vests at 1/12 per month beginning October 27, 2026, alongside five other listed direct option positions.

Rhea-AI Filing Summary

Cryo Cell International Inc. director Daniel Mizrahi was granted 5,300 stock options on October 27, 2026, with a $4.9600 exercise price. The options vest at a rate of 1/12 per month commencing on October 27, 2026, and expire October 27, 2036. Direct common-stock holdings were 30,634 shares as of October 27, 2026; five other direct option positions, each covering 5,300 common shares, are also listed.

Insider Trade Summary

Grant/Award: 5,300 shares

Grant/Award 7 txns

Insider Mizrahi Daniel

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Options F1	5,300	$4.96	$26K
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Options	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Stock Options — 10,600 contracts for 5,300 underlying shares (Direct); Stock Option — 21,200 contracts (Direct); Common Stock — 30,634 shares (Direct)

Footnotes (1)

1. F1. Stock options vest at a rate of 1/12 per month commencing on 10/27/2026.

Key Figures

Stock options granted: 5,300 options Exercise price: $4.9600 per share Vesting rate: 1/12 per month +3 more

6 metrics

Stock options granted 5,300 options Award to director Daniel Mizrahi on October 27, 2026

Exercise price $4.9600 per share For the options granted on October 27, 2026

Vesting rate 1/12 per month Commencing October 27, 2026

Option expiration October 27, 2036 For the options granted on October 27, 2026

Direct common shares 30,634 shares As of October 27, 2026

Other direct option positions 5 positions; 5,300 underlying common shares each Exercise prices: $12.6300, $6.5000, $4.9000, $5.8200, and $4.3500

Key Terms

vest, exercise price, stock options

3 terms

vest financial

"stock options vest at a rate of 1/12 per month"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

exercise price financial

"the $4.9600 exercise price for the awarded options"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

stock options financial

"the 5,300 options awarded to Daniel Mizrahi"

Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many options did CCEL director Daniel Mizrahi receive?

Daniel Mizrahi, a CCEL director, was granted 5,300 stock options on October 27, 2026, at an exercise price of $4.9600 per share; the options expire October 27, 2036.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/28/2026 - 05:00 PM EDT Accepted by SEC EDGAR 10/28/2026 - 05:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mizrahi Daniel

(Last) (First) (Middle)

700 BROOKER CREEK BLVD.

SUITE 1800

(Street)

OLDSMAR FLORIDA 34677

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CRYO CELL INTERNATIONAL INC [ CCEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								30,634	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$12.63							10/20/2021	10/20/2031	Common Stock	5,300		5,300	D
Stock Option	$6.5							10/03/2022	10/03/2032	Common Stock	5,300		5,300	D
Stock Option	$4.9							10/10/2023	10/10/2033	Common Stock	5,300		5,300	D
Stock Option	$5.82							10/29/2024	10/29/2034	Common Stock	5,300		5,300	D
Stock Options	$4.35							10/21/2025	10/21/2035	Common Stock	5,300		5,300	D
Stock Options	$4.96	10/27/2026		A		5,300		10/27/2026(1)	10/27/2036	Common Stock	5,300	$4.96	5,300	D

Explanation of Responses:

1. Stock options vest at a rate of 1/12 per month commencing on 10/27/2026.

	/s/ Daniel Mizrahi	10/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)